SCHEMBL9911210

SCHEMBL9911210

CC[C@H]1O[C@@H](c2ccc3c(=O)[nH]cnn23)[C@](C)(OCc2ccccc2)[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12365715 0.83 HTR1A (0.33) —
SCHEMBL9911209 0.82 — —
SCHEMBL9911190 0.81 TNK2 (0.33) —
SCHEMBL11921415 0.81 TNK2 (0.33) —
SCHEMBL9911192 0.75 — —
SCHEMBL11997785 0.74 IP6K1 (0.31) —
SCHEMBL9911217 0.72 — —
SCHEMBL9911208 0.72 PDE4D (0.35) —
SCHEMBL9911193 0.72 — —
SCHEMBL9911211 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142617-A1 ANTIVIRAL THERAPEUTIC AGENTS BIOCRYST PHARMACEUTICALS, INC. (US) 2012-06-07 — — US disclosed
Send feedback